Park announces three more orders for imaging systems.TORONTO--(BUSINESS WIRE)--April 19, 1995--Park Meditech Inc. (Park) today announced that its subsidiary, Park Medical Systems Inc. (PMSI) has confirmed orders for three more SMART Digital Imaging Systems. The value of the three sales is approximately $2 million. One of the imaging systems will be installed in Nuclear Scanning Inc.'s newest location in Hialeah, Florida. Dr. Henry Pevsner, Associate Professor of Nuclear Medicine, University of Miami This article is about the university in Coral Gables, Florida. For the university in Oxford, Ohio, see Miami University. The University of Miami (also known as Miami of Florida,[2] UM,[3] or just The U School of Medicine, owns and operates seven nuclear medicine centres in South Florida. He stated: "One of the main reasons for selecting Park s system is its potential to perform superior cardiac studies. This system is highly cost effective, and has the features to perform studies usually done on far more expensive imaging modalities." Another system will be installed in the Department of Nuclear Medicine, at William Beaumont Hospital, Royal Oak, Michigan. Dr. Howard J. Dworkin, Director of Nuclear Medicine, and past President of the Society of Nuclear Medicine, operates this extremely busy scanning department at the hospital. PMSI also received an order for a dual head SMART Digital Imaging System from another large hospital in Canada. C. Richard Mullen, President and Chief Executive Officer of PMSI stated: We received one of the orders following the announcement by the Health Care Financing Administration Health Care Financing Administration, n.pr department in the U.S. agency of Health and Human Services responsible for the oversight of the Medicaid and Medicare benefit programs, including guidelines, payment, and coverage policies. (HCFA HCFA abbr. Health Care Financing Administration HCFA, n.pr See Health Care Financing Administration. ) in the U.S. that Medicare will provide reimbursement for myocardial myocardial /myo·car·di·al/ (-kahr´de-al) pertaining to the muscular tissue of the heart. myocardial pertaining to the muscular tissue of the heart (the myocardium). perfusion studies using rubidium-82, a new high energy radioisotope. This is a major development for Park as we are the only company with 510(k) clearance from the FDA for SPECT (Single Photon Emission Computed Tomography single photon emission computed tomography n. Abbr. SPECT Tomographic imaging of local metabolic and physiological functions in tissues. ) systems that perform studies using very high energy radioisotopes. In the past, these studies were performed using Positron Emission Tomography positron emission tomography: see PET scan. positron emission tomography (PET) Imaging technique used in diagnosis and biomedical research. (PET) scanners. Now Park's system has the widest SPECT energy range (50 - 561 KeV) available in the world. Park Meditech Inc. is a medical technology company that specializes in nuclear medicine imaging nuclear medicine imaging, n the diagnostic imaging field that evaluates organ function by injecting isotopes into a structure and documenting the amount of radiation emanating from the tissues. systems. It has developed and patented a totally digital imaging system that offers significantly improved diagnostic capabilities. Park operates internationally through its subsidiaries in developing, manufacturing and marketing imaging technologies, equipment and related computer systems. Park's common shares are listed for trading on the Montreal Exchange under the symbol PKM and on the NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on Small-Cap Market under the symbol PMDTF . CONTACT: Park Meditech Inc., Toronto Corporate Communications, 416/941-8900 or Steve Hanson, Investor Relations (US), 800/595-2357 or Park Medical Systems Inc. C. Richard Mullen, 514/633-9988 INDUSTRY KEYWORD: MEDICINE REPEATS: New York 212-575-8822 or 800-221-2462; Boston 617-330-5311 or |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion